Robatumumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 13:31, 19 August 2009 (Fix typo). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Robatumumab
Monoclonal antibody
Type?
SourceHuman
TargetCD221
Clinical data
ATC code
  • none
Identifiers
CAS Number
Chemical and physical data
FormulaC38714H60189N10637O12187S322
Molar mass879959.96 g·mol−1

Robatumumab (proposed INN) is a monoclonal antibody used as an antineoplastic. It binds to CD221.[1]

References

  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Template:Humanmonoclonals

Retrieved from "https://en.wikipedia.org/w/index.php?title=Robatumumab&oldid=308877063"